+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Basal Cell Carcinoma Treatment Market Analysis & Forecast to 2024-2034

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5923131
The global basal cell carcinoma treatment market size was estimated to be USD 7.36 billion in 2023 and is expected to reach at USD 17.38 billion by 2034 with a CAGR of 8.12% during the forecast period 2024-2034. The increasing occurrence of basal cell carcinoma, advancements in treatment methodologies, heightened awareness among individuals regarding early disease detection, a rise in the prevalence of skin malignancies, a growing elderly population, and increased research & development efforts in the treatment of basal cell carcinoma are some of the key factors boosting the market growth.

Basal cell carcinoma, the most prevalent form of non-melanoma skin cancer, is commonly known as 'rodent ulcers.' The skin's top layer, the epidermis, contains three primary cell types, with basal cells lining these layers. The basal cells undergo shedding or replacement as new ones develop. This carcinoma manifests as open sores, red patches, shiny bumps, or slightly raised growth on the skin with rolled edges. While basal cell carcinoma is generally painless and non-metastatic, there are rare instances where it may spread to other parts of the body. Therefore, increased research & development efforts in the treatment of basal cell carcinoma is predicted to boost the market growth during the forecast period. For instance, in December 2023, AiViva Biopharma reported encouraging results from the phase 1/2 clinical trial of AIV001 (Axitinib), a new intradermal treatment, for patients diagnosed with basal cell carcinoma (BCC).

By treatment, surgery was the highest revenue-grossing segment in the global basal cell carcinoma treatment market in 2023 owing to the increasing advancements in surgical techniques, growing demand for minimally invasive procedures, a heightened awareness of skin cancer, and growing demand for early diagnosis and treatment. Additionally, medications is predicted to grow at the fastest CAGR during the forecast period owing to the advancements in personalized medicine are on the rise, coupled with an increasing awareness of early detection and a surge in regulatory approvals. For instance, in November 2022, According to Regeneron Pharmaceuticals, Inc., Libtayo is now approved by the European Commission (EC) to be used in the treatment of certain patients with advanced basal cell carcinoma (BCC).

By end-user, hospital was the highest revenue-grossing segment in the global basal cell carcinoma treatment market in 2023 owing to the increasing investments are being made to adopt advanced medical devices. Hospitals serve as crucial centers for managing patients, fostering collaboration among healthcare professionals, and advancing research and development. The collaborative endeavors within hospitals are expected to improve cancer care, with a particular emphasis on enhancing patient outcomes, early detection, and tailoring treatment plans based on individual needs. For instance, in September 2022, Royal Hampshire County Hospitals have obtained the FotoFinder equipment to enhance their capabilities in caring for skin cancer. The FotoFinder mole mapping device will significantly transform the dermatology team's ability to identify, monitor, and address skin cancer in patients from the region. Additionally, specialty clinics is predicted to grow at the fastest CAGR during the forecast period owing to the escalating healthcare spending, increasing incidence of basal cell carcinoma, and a growing need for innovative treatment alternatives.

North America region is anticipated for the highest revenue share during the forecast period owing to the increasing occurrence of melanoma cancer, a rising elderly population, heightened research and development initiatives by major market participants, a surge in favorable reimbursement conditions, and an increase in the number of clinical trial processes. For instance, in January 2023, Sirnaomics Ltd. has declared its progression in the clinical development of STP705 to address two non-melanoma skin cancers: Squamous Cell Carcinoma in situ (isSCC) and Basal Cell Carcinoma (BCC). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising occurrence of skin diseases, an increase in awareness about advanced treatments, a growing prevalence of basal cell carcinoma, and heightened collaborations among prominent market players. For instance, in October 2023, Sun Pharma announced that its collaborative partner, the Swiss-Italian biotech company Philogen, has disclosed favorable outcomes from late-stage clinical trials for its novel drug Nidlegy (daromun), designed for the treatment of skin cancers.

Segmentation: Basal Cell Carcinoma Treatment Market Report 2023 - 2034

Basal Cell Carcinoma Treatment Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)

  • Medication
  • Surgery
  • Others

Basal Cell Carcinoma Treatment Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Specialty Clinics
  • Hospitals
  • Others

Basal Cell Carcinoma Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Basal Cell Carcinoma Treatment Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Basal Cell Carcinoma Treatment Market: Treatment Estimates & Trend Analysis
7.1. Treatment Segment Opportunity Analysis
7.2. Medication
7.2.1. Medication Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Surgery
7.3.1. Surgery Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Others
7.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Basal Cell Carcinoma Treatment Market: End-user Estimates & Trend Analysis
8.1. End-user Segment Opportunity Analysis
8.2. Specialty Clinics
8.2.1. Specialty Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Hospitals
8.3.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Others
8.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Regional Market Analysis
9.1. Regional Market Opportunity Analysis
10. North America Basal Cell Carcinoma Treatment Market
10.1. North America Basal Cell Carcinoma Treatment Market
10.1.1. North America Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.1.2. North America Basal Cell Carcinoma Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
10.1.3. North America Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
10.1.4. North America Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
10.2. U.S. Global Basal Cell Carcinoma Treatment Market
10.2.1. U.S. Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.2.2. U.S. Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
10.2.3. U.S. Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
10.3. Canada Global Basal Cell Carcinoma Treatment Market
10.3.1. Canada Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.3.2. Canada Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
10.3.3. Canada Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11. Europe Global Basal Cell Carcinoma Treatment Market
11.1. Europe Global Basal Cell Carcinoma Treatment Market
11.1.1. Europe Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. Europe Basal Cell Carcinoma Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. Europe Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.1.4. Europe Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. Germany Global Basal Cell Carcinoma Treatment Market
11.2.1. Germany Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. Germany Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.2.3. Germany Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. UK Global Basal Cell Carcinoma Treatment Market
11.3.1. UK Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. UK Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.3.3. UK Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.4. France Global Basal Cell Carcinoma Treatment Market
11.4.1. France Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.4.2. France Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.4.3. France Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.5. Spain Global Basal Cell Carcinoma Treatment Market
11.5.1. Spain Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.5.2. Spain Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.5.3. Spain Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.6. Italy Global Basal Cell Carcinoma Treatment Market
11.6.1. Italy Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.6.2. Italy Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.6.3. Italy Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.7. Rest of Europe Global Basal Cell Carcinoma Treatment Market
11.7.1. Rest of Europe Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.7.2. Rest of Europe Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.7.3. Rest of Europe Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Asia Pacific Global Basal Cell Carcinoma Treatment Market
12.1. Asia Pacific Global Basal Cell Carcinoma Treatment Market
12.1.1. Asia Pacific Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Asia Pacific Basal Cell Carcinoma Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Asia Pacific Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.1.4. Asia Pacific Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Japan Global Basal Cell Carcinoma Treatment Market
12.2.1. Japan Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Japan Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.2.3. Japan Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. China Global Basal Cell Carcinoma Treatment Market
12.3.1. China Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. China Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.3.3. China Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. India Global Basal Cell Carcinoma Treatment Market
12.4.1. India Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. India Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.4.3. India Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. South Korea Global Basal Cell Carcinoma Treatment Market
12.5.1. South Korea Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. South Korea Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.5.3. South Korea Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Australia Global Basal Cell Carcinoma Treatment Market
12.6.1. Australia Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Australia Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.6.3. Australia Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Asia Pacific Global Basal Cell Carcinoma Treatment Market
12.7.1. Rest of Asia Pacific Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Asia Pacific Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Asia Pacific Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Latin America Global Basal Cell Carcinoma Treatment Market
13.1. Latin America Global Basal Cell Carcinoma Treatment Market
13.1.1. Latin America Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Latin America Basal Cell Carcinoma Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Latin America Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.1.4. Latin America Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Brazil Global Basal Cell Carcinoma Treatment Market
13.2.1. Brazil Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Brazil Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.2.3. Brazil Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. Mexico Global Basal Cell Carcinoma Treatment Market
13.3.1. Mexico Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. Mexico Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.3.3. Mexico Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. Argentina Global Basal Cell Carcinoma Treatment Market
13.4.1. Argentina Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. Argentina Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.4.3. Argentina Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. Rest of Latin America Global Basal Cell Carcinoma Treatment Market
13.5.1. Rest of Latin America Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Rest of Latin America Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.5.3. Rest of Latin America Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. MEA Global Basal Cell Carcinoma Treatment Market
14.1. MEA Global Basal Cell Carcinoma Treatment Market
14.1.1. MEA Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. MEA Basal Cell Carcinoma Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. MEA Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.1.4. MEA Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. GCC Global Basal Cell Carcinoma Treatment Market
14.2.1. GCC Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. GCC Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.2.3. GCC Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. South Africa Global Basal Cell Carcinoma Treatment Market
14.3.1. South Africa Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. South Africa Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.3.3. South Africa Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Rest of MEA Global Basal Cell Carcinoma Treatment Market
14.4.1. Rest of MEA Basal Cell Carcinoma Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Rest of MEA Basal Cell Carcinoma Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.4.3. Rest of MEA Basal Cell Carcinoma Treatment Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. Competitor Analysis
15.1. Company Market Share Analysis, 2023
15.2. Major Recent Developments
16. Company Profiles
16.1. Medivir AB
16.2. Merck & Co., Inc.
16.3. PellePharm
16.4. Allergan Inc.
16.5. Sanofi
16.6. Bausch Health Companies
16.7. Taro Pharmaceutical Industries Ltd
16.8. Perrigo Company Plc.
16.9. Viatris
16.10. F. Hoffmann-La Roche Ltd.
16.11. Mylan N.V.
16.12. Strides Arcolab Ltd.
16.13. Sun Pharmaceuticals Ltd.
16.14. Other Prominent Players
17. Conclusion18. Recommendations

Companies Mentioned

  • NeonMind BioSciences
  • Cybin Corp.
  • Pfizer Inc.
  • Usona Institute
  • Numinus
  • Jazz Pharmaceuticals
  • Havn Life
  • Revive Therapeutics
  • Seelos Therapeutics
  • PharmaTher Holdings Ltd
  • NRx Pharmaceuticals Inc.
  • Mind Medicine

Table Information